dc.creatorPacheco, R.
dc.date.accessioned2017-10-30T14:11:59Z
dc.date.accessioned2019-05-17T13:54:02Z
dc.date.available2017-10-30T14:11:59Z
dc.date.available2019-05-17T13:54:02Z
dc.date.created2017-10-30T14:11:59Z
dc.date.issued2017
dc.identifierOncotarget. Volume 8, Issue 5, 2017, Pages 7224-7225
dc.identifier1949-2553
dc.identifier. https://doi.org/10.18632/oncotarget.14601
dc.identifierhttp://repositorio.unab.cl/xmlui/handle/ria/4491
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2671103
dc.languageen
dc.publisherImpact Journals LLC
dc.rightshttps://creativecommons.org/licenses/by/3.0/
dc.subjectDopamine receptors
dc.subjectDopaminergic system
dc.subjectInflammatory disorders
dc.subjectNeuroinflammation
dc.subjectNeuroscience
dc.subjectT-cell mediated immunity
dc.titleTargeting dopamine receptor D3 signalling in inflammation
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución